nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—CHRM3—muscle of abdomen—Crohn's disease	0.0521	0.451	CbGeAlD
Scopolamine—Ipratropium bromide—SLC22A4—Crohn's disease	0.0492	0.571	CrCbGaD
Scopolamine—Ipratropium bromide—SLC22A5—Crohn's disease	0.0369	0.429	CrCbGaD
Scopolamine—SI—digestive system—Crohn's disease	0.0219	0.189	CbGeAlD
Scopolamine—Rash generalised—Mesalazine—Crohn's disease	0.0218	0.0604	CcSEcCtD
Scopolamine—Abdominal cramps—Mesalazine—Crohn's disease	0.0137	0.038	CcSEcCtD
Scopolamine—Amblyopia—Mesalazine—Crohn's disease	0.012	0.0333	CcSEcCtD
Scopolamine—CHRM5—epithelium—Crohn's disease	0.0111	0.096	CbGeAlD
Scopolamine—CHRM5—skin of body—Crohn's disease	0.0105	0.0913	CbGeAlD
Scopolamine—Drug withdrawal syndrome—Prednisone—Crohn's disease	0.01	0.0277	CcSEcCtD
Scopolamine—Dry eye—Mesalazine—Crohn's disease	0.00856	0.0237	CcSEcCtD
Scopolamine—Disorientation—Mesalazine—Crohn's disease	0.00752	0.0208	CcSEcCtD
Scopolamine—Eczema—Mesalazine—Crohn's disease	0.00749	0.0207	CcSEcCtD
Scopolamine—Thirst—Mesalazine—Crohn's disease	0.00707	0.0196	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00631	0.0175	CcSEcCtD
Scopolamine—Dry skin—Mesalazine—Crohn's disease	0.00617	0.0171	CcSEcCtD
Scopolamine—Oedema—Mercaptopurine—Crohn's disease	0.00609	0.0169	CcSEcCtD
Scopolamine—CHRM3—smooth muscle tissue—Crohn's disease	0.00597	0.0517	CbGeAlD
Scopolamine—Skin disorder—Mercaptopurine—Crohn's disease	0.00592	0.0164	CcSEcCtD
Scopolamine—Dysphagia—Mesalazine—Crohn's disease	0.00582	0.0161	CcSEcCtD
Scopolamine—Dysuria—Mesalazine—Crohn's disease	0.00544	0.0151	CcSEcCtD
Scopolamine—Conjunctivitis—Mesalazine—Crohn's disease	0.00504	0.014	CcSEcCtD
Scopolamine—Sweating—Mesalazine—Crohn's disease	0.00497	0.0138	CcSEcCtD
Scopolamine—Body temperature increased—Mercaptopurine—Crohn's disease	0.00482	0.0133	CcSEcCtD
Scopolamine—CHRM3—digestive system—Crohn's disease	0.00472	0.0408	CbGeAlD
Scopolamine—Pharyngitis—Mesalazine—Crohn's disease	0.00462	0.0128	CcSEcCtD
Scopolamine—Urinary tract disorder—Mesalazine—Crohn's disease	0.0046	0.0127	CcSEcCtD
Scopolamine—Arrhythmia—Azathioprine—Crohn's disease	0.00456	0.0126	CcSEcCtD
Scopolamine—Urethral disorder—Mesalazine—Crohn's disease	0.00456	0.0126	CcSEcCtD
Scopolamine—Eye disorder—Mesalazine—Crohn's disease	0.00435	0.0121	CcSEcCtD
Scopolamine—Mental disorder—Mesalazine—Crohn's disease	0.00408	0.0113	CcSEcCtD
Scopolamine—Erythema—Mesalazine—Crohn's disease	0.00405	0.0112	CcSEcCtD
Scopolamine—Vomiting—Mercaptopurine—Crohn's disease	0.00387	0.0107	CcSEcCtD
Scopolamine—Rash—Mercaptopurine—Crohn's disease	0.00384	0.0106	CcSEcCtD
Scopolamine—Dermatitis—Mercaptopurine—Crohn's disease	0.00384	0.0106	CcSEcCtD
Scopolamine—Vision blurred—Mesalazine—Crohn's disease	0.00382	0.0106	CcSEcCtD
Scopolamine—Tremor—Mesalazine—Crohn's disease	0.0038	0.0105	CcSEcCtD
Scopolamine—Amnesia—Prednisone—Crohn's disease	0.00379	0.0105	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00376	0.0104	CcSEcCtD
Scopolamine—Vertigo—Mesalazine—Crohn's disease	0.00364	0.0101	CcSEcCtD
Scopolamine—Nausea—Mercaptopurine—Crohn's disease	0.00362	0.01	CcSEcCtD
Scopolamine—Skin disorder—Azathioprine—Crohn's disease	0.00353	0.00977	CcSEcCtD
Scopolamine—Psychotic disorder—Prednisone—Crohn's disease	0.00348	0.00963	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00343	0.00949	CcSEcCtD
Scopolamine—Irritability—Prednisone—Crohn's disease	0.0034	0.00941	CcSEcCtD
Scopolamine—Hypotension—Azathioprine—Crohn's disease	0.00339	0.0094	CcSEcCtD
Scopolamine—Dry mouth—Mesalazine—Crohn's disease	0.00337	0.00935	CcSEcCtD
Scopolamine—Confusional state—Mesalazine—Crohn's disease	0.00333	0.00924	CcSEcCtD
Scopolamine—Oedema—Mesalazine—Crohn's disease	0.00331	0.00916	CcSEcCtD
Scopolamine—Dry skin—Prednisone—Crohn's disease	0.00326	0.00904	CcSEcCtD
Scopolamine—Nervous system disorder—Mesalazine—Crohn's disease	0.00324	0.00899	CcSEcCtD
Scopolamine—Tachycardia—Mesalazine—Crohn's disease	0.00323	0.00894	CcSEcCtD
Scopolamine—Skin disorder—Mesalazine—Crohn's disease	0.00321	0.0089	CcSEcCtD
Scopolamine—Hyperhidrosis—Mesalazine—Crohn's disease	0.0032	0.00886	CcSEcCtD
Scopolamine—Muscular weakness—Prednisone—Crohn's disease	0.00314	0.0087	CcSEcCtD
Scopolamine—Hypotension—Mesalazine—Crohn's disease	0.00309	0.00856	CcSEcCtD
Scopolamine—Feeling abnormal—Azathioprine—Crohn's disease	0.00299	0.00829	CcSEcCtD
Scopolamine—Somnolence—Mesalazine—Crohn's disease	0.00294	0.00815	CcSEcCtD
Scopolamine—Abdominal pain—Azathioprine—Crohn's disease	0.00287	0.00795	CcSEcCtD
Scopolamine—Body temperature increased—Azathioprine—Crohn's disease	0.00287	0.00795	CcSEcCtD
Scopolamine—Fatigue—Mesalazine—Crohn's disease	0.00285	0.0079	CcSEcCtD
Scopolamine—Pain—Mesalazine—Crohn's disease	0.00283	0.00784	CcSEcCtD
Scopolamine—Constipation—Mesalazine—Crohn's disease	0.00283	0.00784	CcSEcCtD
Scopolamine—Feeling abnormal—Mesalazine—Crohn's disease	0.00273	0.00755	CcSEcCtD
Scopolamine—Abdominal pain—Mesalazine—Crohn's disease	0.00261	0.00724	CcSEcCtD
Scopolamine—Body temperature increased—Mesalazine—Crohn's disease	0.00261	0.00724	CcSEcCtD
Scopolamine—Bradycardia—Prednisone—Crohn's disease	0.00251	0.00695	CcSEcCtD
Scopolamine—Hallucination—Prednisone—Crohn's disease	0.00245	0.00679	CcSEcCtD
Scopolamine—ABCB1—epithelium—Crohn's disease	0.00241	0.0209	CbGeAlD
Scopolamine—Dizziness—Azathioprine—Crohn's disease	0.0024	0.00665	CcSEcCtD
Scopolamine—Asthenia—Mesalazine—Crohn's disease	0.00237	0.00657	CcSEcCtD
Scopolamine—Pruritus—Mesalazine—Crohn's disease	0.00234	0.00648	CcSEcCtD
Scopolamine—Vomiting—Azathioprine—Crohn's disease	0.00231	0.0064	CcSEcCtD
Scopolamine—Eye disorder—Prednisone—Crohn's disease	0.0023	0.00638	CcSEcCtD
Scopolamine—Rash—Azathioprine—Crohn's disease	0.00229	0.00634	CcSEcCtD
Scopolamine—Dermatitis—Azathioprine—Crohn's disease	0.00229	0.00634	CcSEcCtD
Scopolamine—Flushing—Prednisone—Crohn's disease	0.00229	0.00633	CcSEcCtD
Scopolamine—Headache—Azathioprine—Crohn's disease	0.00227	0.0063	CcSEcCtD
Scopolamine—Arrhythmia—Prednisone—Crohn's disease	0.0022	0.0061	CcSEcCtD
Scopolamine—Dizziness—Mesalazine—Crohn's disease	0.00219	0.00606	CcSEcCtD
Scopolamine—Mental disorder—Prednisone—Crohn's disease	0.00216	0.00598	CcSEcCtD
Scopolamine—Nausea—Azathioprine—Crohn's disease	0.00216	0.00598	CcSEcCtD
Scopolamine—Erythema—Prednisone—Crohn's disease	0.00214	0.00594	CcSEcCtD
Scopolamine—Vomiting—Mesalazine—Crohn's disease	0.0021	0.00583	CcSEcCtD
Scopolamine—ABCB1—mammalian vulva—Crohn's disease	0.00209	0.0181	CbGeAlD
Scopolamine—Rash—Mesalazine—Crohn's disease	0.00209	0.00578	CcSEcCtD
Scopolamine—Dermatitis—Mesalazine—Crohn's disease	0.00208	0.00577	CcSEcCtD
Scopolamine—Headache—Mesalazine—Crohn's disease	0.00207	0.00574	CcSEcCtD
Scopolamine—Vision blurred—Prednisone—Crohn's disease	0.00202	0.0056	CcSEcCtD
Scopolamine—Agitation—Prednisone—Crohn's disease	0.00197	0.00546	CcSEcCtD
Scopolamine—Nausea—Mesalazine—Crohn's disease	0.00196	0.00544	CcSEcCtD
Scopolamine—Vertigo—Prednisone—Crohn's disease	0.00193	0.00534	CcSEcCtD
Scopolamine—ABCB1—lymphoid tissue—Crohn's disease	0.00186	0.0161	CbGeAlD
Scopolamine—ABCB1—digestive system—Crohn's disease	0.00183	0.0159	CbGeAlD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00181	0.00502	CcSEcCtD
Scopolamine—Oedema—Prednisone—Crohn's disease	0.00175	0.00485	CcSEcCtD
Scopolamine—Nervous system disorder—Prednisone—Crohn's disease	0.00172	0.00475	CcSEcCtD
Scopolamine—Tachycardia—Prednisone—Crohn's disease	0.00171	0.00473	CcSEcCtD
Scopolamine—Skin disorder—Prednisone—Crohn's disease	0.0017	0.00471	CcSEcCtD
Scopolamine—Hyperhidrosis—Prednisone—Crohn's disease	0.00169	0.00469	CcSEcCtD
Scopolamine—Fatigue—Prednisone—Crohn's disease	0.00151	0.00418	CcSEcCtD
Scopolamine—Constipation—Prednisone—Crohn's disease	0.0015	0.00415	CcSEcCtD
Scopolamine—Feeling abnormal—Prednisone—Crohn's disease	0.00144	0.004	CcSEcCtD
Scopolamine—Abdominal pain—Prednisone—Crohn's disease	0.00138	0.00383	CcSEcCtD
Scopolamine—Body temperature increased—Prednisone—Crohn's disease	0.00138	0.00383	CcSEcCtD
Scopolamine—Asthenia—Prednisone—Crohn's disease	0.00126	0.00348	CcSEcCtD
Scopolamine—Pruritus—Prednisone—Crohn's disease	0.00124	0.00343	CcSEcCtD
Scopolamine—Dizziness—Prednisone—Crohn's disease	0.00116	0.00321	CcSEcCtD
Scopolamine—Vomiting—Prednisone—Crohn's disease	0.00111	0.00308	CcSEcCtD
Scopolamine—Rash—Prednisone—Crohn's disease	0.0011	0.00306	CcSEcCtD
Scopolamine—Dermatitis—Prednisone—Crohn's disease	0.0011	0.00305	CcSEcCtD
Scopolamine—Headache—Prednisone—Crohn's disease	0.0011	0.00304	CcSEcCtD
Scopolamine—ABCB1—lymph node—Crohn's disease	0.00105	0.00907	CbGeAlD
Scopolamine—Nausea—Prednisone—Crohn's disease	0.00104	0.00288	CcSEcCtD
Scopolamine—ABCB1—Allograft Rejection—IFNG—Crohn's disease	0.000765	0.00175	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TAGAP—Crohn's disease	0.000758	0.00173	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CCR9—Crohn's disease	0.000754	0.00172	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CCR9—Crohn's disease	0.000751	0.00172	CbGpPWpGaD
Scopolamine—SI—Metabolism—ALB—Crohn's disease	0.000748	0.00171	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CCR9—Crohn's disease	0.000744	0.0017	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—CCR6—Crohn's disease	0.00074	0.00169	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000732	0.00167	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000732	0.00167	CbGpPWpGaD
Scopolamine—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	0.000711	0.00163	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—CCR6—Crohn's disease	0.000709	0.00162	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—GPR65—Crohn's disease	0.000701	0.0016	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—GPR65—Crohn's disease	0.000698	0.0016	CbGpPWpGaD
Scopolamine—CHRM4—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000697	0.00159	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—GPR65—Crohn's disease	0.000692	0.00158	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—RSPO3—Crohn's disease	0.000691	0.00158	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CCR9—Crohn's disease	0.000684	0.00156	CbGpPWpGaD
Scopolamine—ABCB1—Allograft Rejection—IL1B—Crohn's disease	0.000682	0.00156	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CCR9—Crohn's disease	0.000682	0.00156	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CCR9—Crohn's disease	0.000676	0.00154	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—CCR6—Crohn's disease	0.000672	0.00154	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—RSPO3—Crohn's disease	0.000662	0.00151	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SEL1L—Crohn's disease	0.000656	0.0015	CbGpPWpGaD
Scopolamine—SI—Metabolism—PTGS2—Crohn's disease	0.000654	0.0015	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—PTGER4—Crohn's disease	0.000652	0.00149	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.000644	0.00147	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—CCR6—Crohn's disease	0.000644	0.00147	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—GPR65—Crohn's disease	0.000636	0.00145	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PLA2G4F—Crohn's disease	0.000636	0.00145	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—GPR65—Crohn's disease	0.000634	0.00145	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—GPR65—Crohn's disease	0.000628	0.00144	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SEL1L—Crohn's disease	0.000628	0.00143	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—PTGER4—Crohn's disease	0.000624	0.00143	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.000618	0.00141	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ACKR2—Crohn's disease	0.000615	0.00141	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ACKR2—Crohn's disease	0.000613	0.0014	CbGpPWpGaD
Scopolamine—SI—Disease—STAT3—Crohn's disease	0.000609	0.00139	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ACKR2—Crohn's disease	0.000607	0.00139	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCR9—Crohn's disease	0.0006	0.00137	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—PTGER4—Crohn's disease	0.000592	0.00135	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MLN—Crohn's disease	0.000583	0.00133	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MLN—Crohn's disease	0.000581	0.00133	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.00058	0.00133	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.000578	0.00132	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MLN—Crohn's disease	0.000576	0.00132	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCR9—Crohn's disease	0.000574	0.00131	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—PTGER4—Crohn's disease	0.000567	0.0013	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—GPR65—Crohn's disease	0.000557	0.00127	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—IL3—Crohn's disease	0.000555	0.00127	CbGpPWpGaD
Scopolamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000554	0.00127	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.000553	0.00126	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.000551	0.00126	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—MTMR3—Crohn's disease	0.000541	0.00124	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000537	0.00123	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—GPR65—Crohn's disease	0.000534	0.00122	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TAGAP—Crohn's disease	0.000533	0.00122	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TAGAP—Crohn's disease	0.000532	0.00122	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—IL3—Crohn's disease	0.000532	0.00122	CbGpPWpGaD
Scopolamine—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000531	0.00121	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TAGAP—Crohn's disease	0.000527	0.0012	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000516	0.00118	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000514	0.00118	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—IL3—Crohn's disease	0.000504	0.00115	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CCR6—Crohn's disease	0.000499	0.00114	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CCR6—Crohn's disease	0.000498	0.00114	CbGpPWpGaD
Scopolamine—ABCB1—Allograft Rejection—TNF—Crohn's disease	0.000495	0.00113	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CCR6—Crohn's disease	0.000493	0.00113	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—RASGRP1—Crohn's disease	0.000488	0.00111	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—IL3—Crohn's disease	0.000483	0.0011	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—RASGRP1—Crohn's disease	0.000467	0.00107	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—RSPO3—Crohn's disease	0.000466	0.00107	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—RSPO3—Crohn's disease	0.000465	0.00106	CbGpPWpGaD
Scopolamine—CHRM2—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000464	0.00106	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—RSPO3—Crohn's disease	0.00046	0.00105	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000456	0.00104	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CCR6—Crohn's disease	0.000453	0.00104	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CCR6—Crohn's disease	0.000452	0.00103	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000448	0.00102	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CCR6—Crohn's disease	0.000447	0.00102	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SEL1L—Crohn's disease	0.000442	0.00101	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SEL1L—Crohn's disease	0.000441	0.00101	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000439	0.001	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—PTGER4—Crohn's disease	0.000438	0.001	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SEL1L—Crohn's disease	0.000436	0.000997	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—PTGER4—Crohn's disease	0.000434	0.000992	CbGpPWpGaD
Scopolamine—SI—Disease—IL6—Crohn's disease	0.000426	0.000973	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—CXCL8—Crohn's disease	0.000422	0.000965	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—FADS1—Crohn's disease	0.000421	0.000963	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—CXCL8—Crohn's disease	0.000404	0.000924	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCR9—Crohn's disease	0.000404	0.000924	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PLA2G4F—Crohn's disease	0.000403	0.000922	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCR9—Crohn's disease	0.000403	0.000921	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000403	0.00092	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PTGER4—Crohn's disease	0.000399	0.000912	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCR9—Crohn's disease	0.000399	0.000912	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PTGER4—Crohn's disease	0.000398	0.000909	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCR6—Crohn's disease	0.000397	0.000908	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GPX4—Crohn's disease	0.000394	0.000902	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PTGER4—Crohn's disease	0.000394	0.0009	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—IL2RA—Crohn's disease	0.000389	0.000889	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GCKR—Crohn's disease	0.000381	0.000871	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCR6—Crohn's disease	0.00038	0.000869	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GPR65—Crohn's disease	0.000376	0.000859	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GPR65—Crohn's disease	0.000375	0.000856	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—IL3—Crohn's disease	0.000374	0.000856	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000374	0.000854	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—IL3—Crohn's disease	0.000373	0.000853	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000373	0.000852	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—IL2RA—Crohn's disease	0.000372	0.000851	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GPR65—Crohn's disease	0.000371	0.000848	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—IL3—Crohn's disease	0.00037	0.000845	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000369	0.000843	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000362	0.000828	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.000362	0.000827	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000362	0.000827	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000361	0.000825	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—RBX1—Crohn's disease	0.000359	0.000821	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000357	0.000817	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—IL2RA—Crohn's disease	0.000353	0.000807	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PTGER4—Crohn's disease	0.00035	0.000799	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—RBX1—Crohn's disease	0.000344	0.000786	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—MTMR3—Crohn's disease	0.000343	0.000784	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL3—Crohn's disease	0.00034	0.000777	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL3—Crohn's disease	0.000339	0.000774	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—IL2RA—Crohn's disease	0.000338	0.000773	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL3—Crohn's disease	0.000336	0.000767	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PTGER4—Crohn's disease	0.000335	0.000765	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000329	0.000751	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—RASGRP1—Crohn's disease	0.000328	0.000749	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—RASGRP1—Crohn's disease	0.000325	0.000742	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—UBE2D1—Crohn's disease	0.000315	0.00072	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—RIPK2—Crohn's disease	0.000305	0.000698	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—UBE2D1—Crohn's disease	0.000302	0.000689	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—IL6—Crohn's disease	0.000299	0.000684	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL3—Crohn's disease	0.000298	0.000681	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—RIPK2—Crohn's disease	0.000292	0.000668	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—RASGRP1—Crohn's disease	0.000288	0.000658	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL3—Crohn's disease	0.000285	0.000652	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—CXCL8—Crohn's disease	0.000285	0.000651	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—CXCL8—Crohn's disease	0.000284	0.000649	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000284	0.000648	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000283	0.000646	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—CXCL8—Crohn's disease	0.000281	0.000642	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—RASGRP1—Crohn's disease	0.000276	0.00063	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCR6—Crohn's disease	0.000268	0.000612	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—FADS1—Crohn's disease	0.000267	0.000611	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCR6—Crohn's disease	0.000267	0.00061	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCR6—Crohn's disease	0.000264	0.000604	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000262	0.000599	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—JAK2—Crohn's disease	0.000261	0.000597	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—IL2RA—Crohn's disease	0.000261	0.000597	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SOCS1—Crohn's disease	0.000261	0.000596	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—IL2RA—Crohn's disease	0.000259	0.000592	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—JAK2—Crohn's disease	0.00025	0.000572	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GPX4—Crohn's disease	0.00025	0.000572	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SOCS1—Crohn's disease	0.00025	0.000571	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—TYK2—Crohn's disease	0.000249	0.000569	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.000244	0.000558	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—RBX1—Crohn's disease	0.000242	0.000554	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GCKR—Crohn's disease	0.000242	0.000552	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—RBX1—Crohn's disease	0.000241	0.000552	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—RBX1—Crohn's disease	0.000239	0.000546	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—CXCL8—Crohn's disease	0.000239	0.000545	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—TYK2—Crohn's disease	0.000238	0.000545	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL2RA—Crohn's disease	0.000238	0.000544	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—JAK2—Crohn's disease	0.000237	0.000543	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL2RA—Crohn's disease	0.000237	0.000543	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PTGER4—Crohn's disease	0.000236	0.000539	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL2RA—Crohn's disease	0.000235	0.000537	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PTGER4—Crohn's disease	0.000235	0.000537	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PTGER4—Crohn's disease	0.000233	0.000532	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—CXCL8—Crohn's disease	0.000228	0.000522	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—JAK2—Crohn's disease	0.000227	0.00052	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SMAD3—Crohn's disease	0.000225	0.000515	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—CXCL8—Crohn's disease	0.000217	0.000495	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SMAD3—Crohn's disease	0.000216	0.000493	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—UBE2D1—Crohn's disease	0.000212	0.000485	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—UBE2D1—Crohn's disease	0.000212	0.000484	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—UBE2D1—Crohn's disease	0.00021	0.000479	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL2RA—Crohn's disease	0.000209	0.000477	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—CXCL8—Crohn's disease	0.000207	0.000474	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—RIPK2—Crohn's disease	0.000206	0.000471	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—RIPK2—Crohn's disease	0.000205	0.000469	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—RIPK2—Crohn's disease	0.000203	0.000465	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL3—Crohn's disease	0.000201	0.000459	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL3—Crohn's disease	0.0002	0.000458	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL2RA—Crohn's disease	0.0002	0.000457	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL3—Crohn's disease	0.000198	0.000453	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—RASGRP1—Crohn's disease	0.000194	0.000444	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—RASGRP1—Crohn's disease	0.000194	0.000443	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—RASGRP1—Crohn's disease	0.000192	0.000438	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	0.000176	0.000403	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	0.000176	0.000402	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—JAK2—Crohn's disease	0.000176	0.000402	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SOCS1—Crohn's disease	0.000175	0.000401	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	0.000174	0.000398	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	0.000174	0.000397	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	0.000168	0.000383	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—TYK2—Crohn's disease	0.000167	0.000382	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	0.000166	0.000379	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000164	0.000375	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000161	0.000368	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CXCL8—Crohn's disease	0.00016	0.000366	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	0.00016	0.000366	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—JAK2—Crohn's disease	0.00016	0.000365	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	0.000159	0.000363	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	0.000158	0.000361	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	0.000152	0.000347	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SMAD3—Crohn's disease	0.000151	0.000346	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	0.00015	0.000343	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TYK2—Crohn's disease	0.000147	0.000336	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	0.000146	0.000334	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CXCL8—Crohn's disease	0.000146	0.000333	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	0.000144	0.00033	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TYK2—Crohn's disease	0.000141	0.000322	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	0.000141	0.000322	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—JAK2—Crohn's disease	0.00014	0.00032	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL2RA—Crohn's disease	0.00014	0.00032	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	0.000139	0.000317	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—JAK2—Crohn's disease	0.000134	0.000307	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CXCL8—Crohn's disease	0.000128	0.000293	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CXCL8—Crohn's disease	0.000123	0.00028	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—IL6—Crohn's disease	0.000122	0.000278	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ALB—Crohn's disease	0.000121	0.000277	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—IL6—Crohn's disease	0.000117	0.000266	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PTGS2—Crohn's disease	0.000106	0.000242	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—STAT3—Crohn's disease	0.000103	0.000235	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TYK2—Crohn's disease	9.91e-05	0.000227	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TYK2—Crohn's disease	9.88e-05	0.000226	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—STAT3—Crohn's disease	9.86e-05	0.000225	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TYK2—Crohn's disease	9.78e-05	0.000224	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—JAK2—Crohn's disease	9.45e-05	0.000216	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—JAK2—Crohn's disease	9.42e-05	0.000215	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—JAK2—Crohn's disease	9.33e-05	0.000213	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	8.63e-05	0.000197	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CXCL8—Crohn's disease	8.6e-05	0.000197	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	8.52e-05	0.000195	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL6—Crohn's disease	8.21e-05	0.000188	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL6—Crohn's disease	8.18e-05	0.000187	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL6—Crohn's disease	8.1e-05	0.000185	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ALB—Crohn's disease	7.69e-05	0.000176	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL6—Crohn's disease	7.19e-05	0.000164	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—STAT3—Crohn's disease	6.94e-05	0.000159	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—STAT3—Crohn's disease	6.92e-05	0.000158	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL6—Crohn's disease	6.88e-05	0.000157	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—STAT3—Crohn's disease	6.85e-05	0.000157	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PTGS2—Crohn's disease	6.73e-05	0.000154	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL6—Crohn's disease	4.85e-05	0.000111	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL6—Crohn's disease	4.83e-05	0.00011	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL6—Crohn's disease	4.78e-05	0.000109	CbGpPWpGaD
